Left Atrial Thrombus-Are All Atria and Appendages Equal?


Journal

Interventional cardiology clinics
ISSN: 2211-7466
Titre abrégé: Interv Cardiol Clin
Pays: Netherlands
ID NLM: 101615153

Informations de publication

Date de publication:
04 2022
Historique:
entrez: 1 4 2022
pubmed: 2 4 2022
medline: 5 4 2022
Statut: ppublish

Résumé

Although the left atrial appendage (LAA) seems useless, it has several critical functions that are not fully known yet, such as the causes for being the main origin of cardioembolic stroke. Difficulties arise due to the extreme range of LAA morphologic variability, making the definition of normality challenging and hampering the stratification of thrombotic risk. Furthermore, obtaining quantitative metrics of its anatomy and function from patient data is not straightforward. A multimodality imaging approach, using advanced computational tools for their analysis, allows a complete characterization of the LAA to individualize medical decisions related to left atrial thrombosis patients.

Identifiants

pubmed: 35361457
pii: S2211-7458(21)00109-7
doi: 10.1016/j.iccl.2021.11.005
pii:
doi:

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

121-134

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Disclosure This work was supported by the Spanish Ministry of Economy and Competitiveness under the Retos Investigacion project (RTI2018-101193-B-I00) and by the H2020 EU SimCardioTest project (Digital transformation in Health and Care SC1-DTH-06-2020; grant agreement No. 101016496)..

Auteurs

Alberto Cresti (A)

Cardiology Department, Misericordia Hospital, Azienda Sanitaria Toscana SudEst, Via Senese, Grosseto 58100, Italy.

Oscar Camara (O)

BCN MedTech, Department of Information and Communication Technologies, Universitat Pompeu Fabra, Tànger 122, Barcelona 08018, Spain. Electronic address: oscar.camara@upf.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH